XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 31.80

-0.1%

Nov 21 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert K. who wrote (4957)	11/30/1997 11:16:00 AM
From: aknahow	Read Replies (1) of 17367

Bob, IDEC PHARM a.r. footnote describes License fee income in detail,(not percents), but amounts receivd and from whom. On the expense side not as clear but shows $1.3 million expense for certain patent rights related to C2B8. This method would get around inability to disclose percents due to contractual restraints, if any. It would facilitate our own calculations. Hope Xoma uses it.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next